EU One Step Closer To Confirming EMA's New Pivotal Role In Device Matters
Executive Summary
Industry opposes the proposed new role of European Medicines Agency in overseeing devices availability in a healthcare crisis. But a new Regulation may be adopted in March and its fallout looks set to herald a new era for device supply management and regulation.
You may also be interested in...
Proposal For EMA To Provide Medtech Expert Panel Structure Gains Traction
The medtech industry has long resisted having the European Medicines Agency involved in device oversight. Now an EU-level proposal is making device makers nervous.
European Regulatory Roundup, November 2021: Eudamed Dominates News
Updates and speculation surrounding the Eudamed medtech database has attracted significant attention in November. It was also an impactful month for IVDR news too, and for moves strengthening the medtech and pharma interface.
Commission Publishes Implementing Regulation That Acts As Basic Starter Manual For Eudamed
The European Commission has published an Implementing Regulation explaining some of the fundamental practices that need to be carried out by different actors from the beginning for Eudamed to operate successfully.